{"id":"https://openalex.org/W4390920172","doi":"https://doi.org/10.1016/j.jbc.2024.105650","title":"Revealing the mechanism of action of a first-in-class covalent inhibitor of KRASG12C (ON) and other functional properties of oncogenic KRAS by 31P NMR","display_name":"Revealing the mechanism of action of a first-in-class covalent inhibitor of KRASG12C (ON) and other functional properties of oncogenic KRAS by 31P NMR","publication_year":2024,"publication_date":"2024-01-16","ids":{"openalex":"https://openalex.org/W4390920172","doi":"https://doi.org/10.1016/j.jbc.2024.105650","pmid":"https://pubmed.ncbi.nlm.nih.gov/38237681","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10877953"},"language":"en","primary_location":{"id":"doi:10.1016/j.jbc.2024.105650","doi":"https://doi.org/10.1016/j.jbc.2024.105650","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jbc.2024.105650","pdf_url":null,"source":{"id":"https://openalex.org/S140251998","display_name":"Journal of Biological Chemistry","issn_l":"0021-9258","issn":["0021-9258","1067-8816","1083-351X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Biological Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.jbc.2024.105650","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100621624","display_name":"Alok Kumar Sharma","orcid":"https://orcid.org/0000-0001-8011-1074","observed_orcids":["https://orcid.org/0000-0001-8011-1074"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Alok K. Sharma","raw_affiliation_strings":["NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA. Electronic address: alok.sharma@nih.gov","NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA"],"raw_orcid":"https://orcid.org/0000-0001-8011-1074","affiliations":[{"raw_affiliation_string":"NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA. Electronic address: alok.sharma@nih.gov","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]},{"raw_affiliation_string":"NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jun Pei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jun Pei","raw_affiliation_strings":["Physical and Life Sciences (PLS) Directorate, Lawrence Livermore National Laboratory, Livermore, California, USA","Physical and Life Sciences (PLS) Directorate, Lawrence Livermore National Laboratory, Livermore, California 94550, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Physical and Life Sciences (PLS) Directorate, Lawrence Livermore National Laboratory, Livermore, California, USA","institution_ids":["https://openalex.org/I1282311441"]},{"raw_affiliation_string":"Physical and Life Sciences (PLS) Directorate, Lawrence Livermore National Laboratory, Livermore, California 94550, USA","institution_ids":["https://openalex.org/I1282311441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058777008","display_name":"Yue Yang","orcid":"https://orcid.org/0000-0001-5670-9551","observed_orcids":["https://orcid.org/0000-0001-5670-9551"]},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yue Yang","raw_affiliation_strings":["Physical and Life Sciences (PLS) Directorate, Lawrence Livermore National Laboratory, Livermore, California, USA","Physical and Life Sciences (PLS) Directorate, Lawrence Livermore National Laboratory, Livermore, California 94550, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Physical and Life Sciences (PLS) Directorate, Lawrence Livermore National Laboratory, Livermore, California, USA","institution_ids":["https://openalex.org/I1282311441"]},{"raw_affiliation_string":"Physical and Life Sciences (PLS) Directorate, Lawrence Livermore National Laboratory, Livermore, California 94550, USA","institution_ids":["https://openalex.org/I1282311441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015198096","display_name":"Marcin D. Dyba","orcid":"https://orcid.org/0000-0001-6311-6877","observed_orcids":["https://orcid.org/0000-0001-6311-6877"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcin Dyba","raw_affiliation_strings":["NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA","NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA"],"raw_orcid":"https://orcid.org/0000-0001-6311-6877","affiliations":[{"raw_affiliation_string":"NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4396570585"]},{"raw_affiliation_string":"NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070403672","display_name":"Brian D. Smith","orcid":"https://orcid.org/0000-0002-4649-120X","observed_orcids":["https://orcid.org/0000-0002-4649-120X"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Smith","raw_affiliation_strings":["NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA","NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4396570585"]},{"raw_affiliation_string":"NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061895849","display_name":"Dana Rabara","orcid":"https://orcid.org/0009-0008-7411-3418","observed_orcids":["https://orcid.org/0009-0008-7411-3418"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dana Rabara","raw_affiliation_strings":["NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA","NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA"],"raw_orcid":"https://orcid.org/0009-0008-7411-3418","affiliations":[{"raw_affiliation_string":"NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4396570585"]},{"raw_affiliation_string":"NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071656740","display_name":"Erik K. Larsen","orcid":"https://orcid.org/0000-0002-7553-212X","observed_orcids":["https://orcid.org/0000-0002-7553-212X"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erik K. Larsen","raw_affiliation_strings":["NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA","NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA"],"raw_orcid":"https://orcid.org/0000-0002-7553-212X","affiliations":[{"raw_affiliation_string":"NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4396570585"]},{"raw_affiliation_string":"NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020056606","display_name":"Felice C. Lightstone","orcid":"https://orcid.org/0000-0003-1465-426X","observed_orcids":["https://orcid.org/0000-0003-1465-426X"]},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Felice C. Lightstone","raw_affiliation_strings":["Physical and Life Sciences (PLS) Directorate, Lawrence Livermore National Laboratory, Livermore, California, USA","Physical and Life Sciences (PLS) Directorate, Lawrence Livermore National Laboratory, Livermore, California 94550, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Physical and Life Sciences (PLS) Directorate, Lawrence Livermore National Laboratory, Livermore, California, USA","institution_ids":["https://openalex.org/I1282311441"]},{"raw_affiliation_string":"Physical and Life Sciences (PLS) Directorate, Lawrence Livermore National Laboratory, Livermore, California 94550, USA","institution_ids":["https://openalex.org/I1282311441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070319506","display_name":"Dominic Esposito","orcid":"https://orcid.org/0000-0002-9987-1687","observed_orcids":["https://orcid.org/0000-0002-9987-1687"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dominic Esposito","raw_affiliation_strings":["NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA","NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4396570585"]},{"raw_affiliation_string":"NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070024846","display_name":"Andrew G. Stephen","orcid":"https://orcid.org/0000-0002-8259-621X","observed_orcids":["https://orcid.org/0000-0002-8259-621X"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew G. Stephen","raw_affiliation_strings":["NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA","NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4396570585"]},{"raw_affiliation_string":"NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100372343","display_name":"Bin Wang","orcid":"https://orcid.org/0000-0002-2712-9045","observed_orcids":["https://orcid.org/0000-0002-2712-9045","https://orcid.org/0000-0002-2273-3315"]},"institutions":[{"id":"https://openalex.org/I4210136306","display_name":"BridgeBio (United States)","ror":"https://ror.org/0394gjn55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136306"]},{"id":"https://openalex.org/I4405263923","display_name":"BridgeBio Oncology Therapeutics (United States)","ror":"https://ror.org/00e3m0q94","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bin Wang","raw_affiliation_strings":["BridgeBio Oncology Therapeutics, BridgeBio Pharma, Inc, Palo Alto, California, USA","BridgeBio Oncology Therapeutics, BridgeBio Pharma, Inc., 3160 Porter Drive, Palo Alto, 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BridgeBio Oncology Therapeutics, BridgeBio Pharma, Inc, Palo Alto, California, USA","institution_ids":["https://openalex.org/I4210136306","https://openalex.org/I4405263923"]},{"raw_affiliation_string":"BridgeBio Oncology Therapeutics, BridgeBio Pharma, Inc., 3160 Porter Drive, Palo Alto, 94304, USA","institution_ids":["https://openalex.org/I4210136306","https://openalex.org/I4405263923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019770407","display_name":"Pedro J. Beltran","orcid":"https://orcid.org/0000-0002-4103-6494","observed_orcids":["https://orcid.org/0000-0002-4103-6494"]},"institutions":[{"id":"https://openalex.org/I4210136306","display_name":"BridgeBio (United States)","ror":"https://ror.org/0394gjn55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136306"]},{"id":"https://openalex.org/I4405263923","display_name":"BridgeBio Oncology Therapeutics (United States)","ror":"https://ror.org/00e3m0q94","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pedro J. Beltran","raw_affiliation_strings":["BridgeBio Oncology Therapeutics, BridgeBio Pharma, Inc, Palo Alto, California, USA","BridgeBio Oncology Therapeutics, BridgeBio Pharma, Inc., 3160 Porter Drive, Palo Alto, 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BridgeBio Oncology Therapeutics, BridgeBio Pharma, Inc, Palo Alto, California, USA","institution_ids":["https://openalex.org/I4210136306","https://openalex.org/I4405263923"]},{"raw_affiliation_string":"BridgeBio Oncology Therapeutics, BridgeBio Pharma, Inc., 3160 Porter Drive, Palo Alto, 94304, USA","institution_ids":["https://openalex.org/I4210136306","https://openalex.org/I4405263923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114048089","display_name":"Eli M. Wallace","orcid":"https://orcid.org/0009-0006-1692-7160","observed_orcids":["https://orcid.org/0009-0006-1692-7160"]},"institutions":[{"id":"https://openalex.org/I4210136306","display_name":"BridgeBio (United States)","ror":"https://ror.org/0394gjn55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136306"]},{"id":"https://openalex.org/I4405263923","display_name":"BridgeBio Oncology Therapeutics (United States)","ror":"https://ror.org/00e3m0q94","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eli Wallace","raw_affiliation_strings":["BridgeBio Oncology Therapeutics, BridgeBio Pharma, Inc, Palo Alto, California, USA","BridgeBio Oncology Therapeutics, BridgeBio Pharma, Inc., 3160 Porter Drive, Palo Alto, 94304, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BridgeBio Oncology Therapeutics, BridgeBio Pharma, Inc, Palo Alto, California, USA","institution_ids":["https://openalex.org/I4210136306","https://openalex.org/I4405263923"]},{"raw_affiliation_string":"BridgeBio Oncology Therapeutics, BridgeBio Pharma, Inc., 3160 Porter Drive, Palo Alto, 94304, USA","institution_ids":["https://openalex.org/I4210136306","https://openalex.org/I4405263923"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046377031","display_name":"Dwight V. Nissley","orcid":"https://orcid.org/0000-0001-7523-116X","observed_orcids":["https://orcid.org/0000-0001-7523-116X"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dwight V. Nissley","raw_affiliation_strings":["NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA","NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA"],"raw_orcid":"https://orcid.org/0000-0001-7523-116X","affiliations":[{"raw_affiliation_string":"NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4396570585"]},{"raw_affiliation_string":"NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082685256","display_name":"Frank P. McCormick","orcid":"https://orcid.org/0000-0002-6619-7120","observed_orcids":["https://orcid.org/0000-0002-6619-7120"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210136306","display_name":"BridgeBio (United States)","ror":"https://ror.org/0394gjn55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136306"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]},{"id":"https://openalex.org/I4405263923","display_name":"BridgeBio Oncology Therapeutics (United States)","ror":"https://ror.org/00e3m0q94","country_code":"US","type":"company","lineage":["https://openalex.org/I4405263923"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank McCormick","raw_affiliation_strings":["NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA; BridgeBio Oncology Therapeutics, BridgeBio Pharma, Inc, Palo Alto, California, USA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA","BridgeBio Oncology Therapeutics, BridgeBio Pharma, Inc., 3160 Porter Drive, Palo Alto, 94304, USA","Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1450 3rd Street, San Francisco, California 94158, USA","NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA; BridgeBio Oncology Therapeutics, BridgeBio Pharma, Inc, Palo Alto, California, USA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210167126","https://openalex.org/I4396570585","https://openalex.org/I4405263923"]},{"raw_affiliation_string":"BridgeBio Oncology Therapeutics, BridgeBio Pharma, Inc., 3160 Porter Drive, Palo Alto, 94304, USA","institution_ids":["https://openalex.org/I4210136306","https://openalex.org/I4405263923"]},{"raw_affiliation_string":"Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1450 3rd Street, San Francisco, California 94158, USA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]},{"raw_affiliation_string":"NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000314948","display_name":"Anna E. Maciag","orcid":"https://orcid.org/0000-0001-6562-5640","observed_orcids":["https://orcid.org/0000-0001-6562-5640"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4396570585","display_name":"Leidos Biomedical Research Inc. (United States)","ror":"https://ror.org/00bardy64","country_code":"US","type":"company","lineage":["https://openalex.org/I114662689","https://openalex.org/I4396570585"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Anna E. Maciag","raw_affiliation_strings":["NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA. Electronic address: anna.maciag@nih.gov","NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA. Electronic address: anna.maciag@nih.gov","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]},{"raw_affiliation_string":"NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21701, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5000314948","https://openalex.org/A5100621624"],"corresponding_institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4396570585"],"apc_list":{"value":2800,"currency":"USD","value_usd":2800},"apc_paid":{"value":2800,"currency":"USD","value_usd":2800},"fwci":2.7802,"has_fulltext":true,"cited_by_count":25,"citation_normalized_percentile":{"value":0.92405461,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"300","issue":"2","first_page":"105650","last_page":"105650"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kras-g12c","display_name":"KRAS G12C","score":0.9359999895095825},{"id":"https://openalex.org/keywords/covalent-kras-inhibitor","display_name":"covalent KRAS inhibitor","score":0.8999999761581421},{"id":"https://openalex.org/keywords/gpp-nh-p","display_name":"Gpp(NH)p","score":0.7730000019073486},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.7400000095367432},{"id":"https://openalex.org/keywords/31p-nmr-spectroscopy","display_name":"31P NMR","score":0.7509999871253967},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.503000020980835}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.8426064252853394},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.670075535774231},{"id":"https://openalex.org/C118716","wikidata":"https://www.wikidata.org/wiki/Q5514725","display_name":"GTP'","level":3,"score":0.6446245908737183},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5274477601051331},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.495825856924057},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.49217453598976135},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.47573092579841614},{"id":"https://openalex.org/C207332259","wikidata":"https://www.wikidata.org/wiki/Q769143","display_name":"GTPase","level":2,"score":0.46945375204086304},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.45294708013534546},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4525134861469269},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.42374956607818604},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4127289354801178},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.352450966835022},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.35163649916648865},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.33078527450561523},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.3248981535434723},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.3065161108970642},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.266926646232605},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08024659752845764},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.07423719763755798},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D006160","descriptor_name":"Guanosine Triphosphate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009682","descriptor_name":"Magnetic Resonance Spectroscopy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016283","descriptor_name":"Proto-Oncogene Proteins p21(ras)","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D016283","descriptor_name":"Proto-Oncogene Proteins p21(ras)","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018631","descriptor_name":"ras Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1016/j.jbc.2024.105650","doi":"https://doi.org/10.1016/j.jbc.2024.105650","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jbc.2024.105650","pdf_url":null,"source":{"id":"https://openalex.org/S140251998","display_name":"Journal of Biological Chemistry","issn_l":"0021-9258","issn":["0021-9258","1067-8816","1083-351X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Biological Chemistry","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10877953","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10877953","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10877953/pdf/main.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Biol Chem","raw_type":"Text"},{"id":"pmid:38237681","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38237681","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of biological chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt6xq096vr","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/6xq096vr","pdf_url":"https://escholarship.org/content/qt6xq096vr/qt6xq096vr.pdf?t=s9i9xe","source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Biological Chemistry, vol 300, iss 2","raw_type":"article"},{"id":"pmh:oai:osti.gov:2345116","doi":null,"is_oa":true,"landing_page_url":"https://www.osti.gov/biblio/2345116","pdf_url":"https://www.osti.gov/servlets/purl/2345116","source":{"id":"https://openalex.org/S4306402487","display_name":"OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I139351228","host_organization_name":"Office of Scientific and Technical Information","host_organization_lineage":["https://openalex.org/I139351228"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"doi:10.1016/j.jbc.2024.105650","doi":"https://doi.org/10.1016/j.jbc.2024.105650","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jbc.2024.105650","pdf_url":null,"source":{"id":"https://openalex.org/S140251998","display_name":"Journal of Biological Chemistry","issn_l":"0021-9258","issn":["0021-9258","1067-8816","1083-351X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Biological Chemistry","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[{"id":"https://openalex.org/G1234541941","display_name":null,"funder_award_id":"75N91019D00024","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G1356433355","display_name":null,"funder_award_id":"DE\u2010AC5207NA27344","funder_id":"https://openalex.org/F4320338286","funder_display_name":"Lawrence Livermore National Laboratory"},{"id":"https://openalex.org/G14554683","display_name":null,"funder_award_id":"DEAC5207NA27344","funder_id":"https://openalex.org/F4320306084","funder_display_name":"U.S. Department of Energy"},{"id":"https://openalex.org/G1716777315","display_name":null,"funder_award_id":"DE-AC52-07NA27344","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G2132873222","display_name":null,"funder_award_id":"75N91019D00024","funder_id":"https://openalex.org/F4320313762","funder_display_name":"Frederick National Laboratory for Cancer Research"},{"id":"https://openalex.org/G2145270357","display_name":null,"funder_award_id":"AC52\u201007NA27344","funder_id":"https://openalex.org/F4320306084","funder_display_name":"U.S. Department of Energy"},{"id":"https://openalex.org/G3094789770","display_name":null,"funder_award_id":"75N91019D00024","funder_id":"https://openalex.org/F4320306084","funder_display_name":"U.S. Department of Energy"},{"id":"https://openalex.org/G3669113783","display_name":null,"funder_award_id":"07NA27344","funder_id":"https://openalex.org/F4320338286","funder_display_name":"Lawrence Livermore National Laboratory"},{"id":"https://openalex.org/G4051559466","display_name":null,"funder_award_id":"TC02290","funder_id":"https://openalex.org/F4320313762","funder_display_name":"Frederick National Laboratory for Cancer Research"},{"id":"https://openalex.org/G4689185066","display_name":null,"funder_award_id":"75N91019D00024","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4822472444","display_name":null,"funder_award_id":"LLNL-JRNL-853388","funder_id":"https://openalex.org/F4320306084","funder_display_name":"U.S. Department of Energy"},{"id":"https://openalex.org/G6252953675","display_name":null,"funder_award_id":"75N91019D00024","funder_id":"https://openalex.org/F4320306085","funder_display_name":"U.S. Department of Health and Human Services"},{"id":"https://openalex.org/G632693473","display_name":null,"funder_award_id":"DE-AC52-07NA27344","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G895790057","display_name":null,"funder_award_id":"DE-AC52","funder_id":"https://openalex.org/F4320338286","funder_display_name":"Lawrence Livermore National Laboratory"},{"id":"https://openalex.org/G991281326","display_name":null,"funder_award_id":"AC52-07NA27344","funder_id":"https://openalex.org/F4320338286","funder_display_name":"Lawrence Livermore National Laboratory"}],"funders":[{"id":"https://openalex.org/F4320306084","display_name":"U.S. Department of Energy","ror":"https://ror.org/01bj3aw27"},{"id":"https://openalex.org/F4320306085","display_name":"U.S. Department of Health and Human Services","ror":"https://ror.org/033jnv181"},{"id":"https://openalex.org/F4320313762","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320338286","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4390920172.pdf","grobid_xml":"https://content.openalex.org/works/W4390920172.grobid-xml"},"referenced_works_count":56,"referenced_works":["https://openalex.org/W1508559184","https://openalex.org/W1872665193","https://openalex.org/W1953264505","https://openalex.org/W1964930474","https://openalex.org/W1969836007","https://openalex.org/W1978609220","https://openalex.org/W1987365716","https://openalex.org/W1989233227","https://openalex.org/W2018019331","https://openalex.org/W2024944232","https://openalex.org/W2031842520","https://openalex.org/W2033204562","https://openalex.org/W2035687084","https://openalex.org/W2040809566","https://openalex.org/W2053423866","https://openalex.org/W2063254536","https://openalex.org/W2067174909","https://openalex.org/W2073801668","https://openalex.org/W2073967748","https://openalex.org/W2080719056","https://openalex.org/W2106140689","https://openalex.org/W2121951430","https://openalex.org/W2128339707","https://openalex.org/W2159594827","https://openalex.org/W2168033476","https://openalex.org/W2168770561","https://openalex.org/W2233032895","https://openalex.org/W2300615341","https://openalex.org/W2325656664","https://openalex.org/W2404280981","https://openalex.org/W2467146058","https://openalex.org/W2604819411","https://openalex.org/W2611685413","https://openalex.org/W2717068414","https://openalex.org/W2785187242","https://openalex.org/W2799702558","https://openalex.org/W2803265095","https://openalex.org/W2947624034","https://openalex.org/W2956719127","https://openalex.org/W2965941158","https://openalex.org/W2982321167","https://openalex.org/W2982602983","https://openalex.org/W2998581726","https://openalex.org/W3007721372","https://openalex.org/W3013377779","https://openalex.org/W3038485915","https://openalex.org/W3075491940","https://openalex.org/W3131852822","https://openalex.org/W3142010099","https://openalex.org/W3174662367","https://openalex.org/W3207701655","https://openalex.org/W4223470164","https://openalex.org/W4225365581","https://openalex.org/W4379197341","https://openalex.org/W4385931420","https://openalex.org/W4386225337"],"related_works":["https://openalex.org/W4404691520","https://openalex.org/W4367553334","https://openalex.org/W2799702558","https://openalex.org/W2300615341","https://openalex.org/W4379197341","https://openalex.org/W4393989591","https://openalex.org/W4214590973","https://openalex.org/W3171180761","https://openalex.org/W7133714671","https://openalex.org/W2940434391"],"abstract_inverted_index":{"Individual":[0],"oncogenic":[1,71,152],"KRAS":[2,19,70,105,153,168,189,216],"mutants":[3,72],"confer":[4],"distinct":[5],"differences":[6,56],"in":[7,57,65,111,128,140,214],"biochemical":[8],"properties":[9],"and":[10,27,40,60,68,77,127,135,163,187,207],"signaling":[11,230],"for":[12,245],"reasons":[13],"that":[14,95,119,193],"are":[15],"not":[16],"well":[17],"understood.":[18],"activity":[20],"is":[21,28,106,131,136,182,225],"closely":[22],"coupled":[23],"to":[24,53,80,133,227],"protein":[25],"dynamics":[26],"regulated":[29],"through":[30],"two":[31],"interconverting":[32],"conformations:":[33],"state":[34,41,58,61,100,113,123,201,204,211,232],"1":[35,59,101,124,202,212],"(inactive,":[36],"effector":[37,44,157],"binding":[38,45,162,194],"deficient),":[39],"2":[42,62,114,205,233],"(active,":[43],"enabled).":[46],"Here":[47],"we":[48,172],"use":[49],"31":[50],"P":[51],"NMR":[52],"delineate":[54],"the":[55,112,120,144,200,219,236,240],"populations":[63],"present":[64],"wild-type":[66],"(WT)":[67],"common":[69],"(G12C,":[73],"G12D,":[74],"G12V,":[75],"G13D,":[76],"Q61L)":[78],"bound":[79],"its":[81],"natural":[82],"substrate":[83],"GTP":[84],"or":[85,109],"a":[86,167,175,229],"commonly":[87],"used":[88],"nonhydrolyzable":[89],"analogue":[90],"GppNHp.":[91],"Our":[92],"results":[93],"show":[94,192],"GppNHp-bound":[96],"proteins":[97],"exhibit":[98],"significant":[99],"population,":[102],"whereas":[103],"GTP-bound":[104,188,215],"primarily":[107],"(90%":[108],"more)":[110],"conformation.":[115],"This":[116],"observation":[117],"suggests":[118],"predominance":[121],"of":[122,146,151,195,221,242],"shown":[125],"here":[126],"other":[129],"studies":[130],"related":[132],"GppNHp":[134],"most":[137],"likely":[138],"nonexistent":[139],"cells.":[141],"We":[142,191],"characterize":[143],"impact":[145],"this":[147,196,246],"differential":[148],"conformational":[149],"equilibrium":[150,206],"on":[154],"RAF1":[155,223],"kinase":[156],"RBD":[158,224],"(RAS":[159],"Binding":[160],"Domain)":[161],"intrinsic":[164],"hydrolysis.":[165],"Through":[166],"G12C":[169],"drug":[170],"discovery,":[171],"have":[173],"identified":[174],"novel":[176],"small":[177],"molecule":[178],"inhibitor,":[179],"BBO-8956,":[180,222],"which":[181],"effective":[183],"against":[184],"both":[185],"GDP":[186],"G12C.":[190,217],"inhibitor":[197],"significantly":[198],"perturbs":[199],"-":[203],"induces":[208],"an":[209],"inactive":[210],"conformation":[213,234],"In":[218],"presence":[220],"unable":[226],"induce":[228],"competent":[231],"within":[235],"ternary":[237],"complex,":[238],"demonstrating":[239],"mechanism":[241],"action":[243],"(MOA)":[244],"novel,":[247],"active-conformation":[248],"inhibitor.":[249]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":7}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2024-01-17T00:00:00"}